C12N 2795/10321
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2795/10321 (Viruses as such) appears on 72 US grants and 113 published applications in this corpus.
Search patents in C12N- Granted patents
- 72
- Published applications
- 113
- Assignees
- 64
- Inventors
- 214
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 3 |
| 2011 | 0 | 5 |
| 2012 | 3 | 2 |
| 2013 | 1 | 2 |
| 2014 | 3 | 5 |
| 2015 | 1 | 2 |
| 2016 | 2 | 7 |
| 2017 | 5 | 4 |
| 2018 | 2 | 5 |
| 2019 | 8 | 8 |
| 2020 | 4 | 8 |
| 2021 | 3 | 12 |
| 2022 | 7 | 13 |
| 2023 | 7 | 8 |
| 2024 | 12 | 15 |
| 2025 | 7 | 6 |
| 2026 | 3 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bacteriophages for treatment of tuberculosis31 Mar 2026US 12,589,127 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Compositions comprising Propionibacterium acnes bacteriophages for treating acne17 Mar 2026US 12,576,024 B2Phi Therapeutics, Inc.
- Bacteriophages for the treatment of tuberculosis17 Mar 2026US 12,576,118 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Phage-derived particles for in situ delivery of DNA payload into C. acnes population4 Nov 2025US 12,460,216 B2Eligo Bioscience
- Cutibacterium acnes recombinant phages encoding a human protein28 Oct 2025US 12,454,696 B2Eligo Bioscience
- Bacteriophages as a tool to manipulate gut commensal immune-modulation activity17 Sep 2026US 2026/0273002 A1Technion Research & Development Foundation Limited
- Cutibacterium acnes recombinant phages, method of production and uses thereof6 Aug 2026US 2026/0226484 A1Eligo Bioscience
- Staphylococcus phage compositions and cocktails thereof7 May 2026US 2026/0124259 A1Locus Biosciences, Inc.
- Bacteriophage compositions and methods for treatment of bacterial infections23 Apr 2026US 2026/0108570 A1The University of Chicago
- Phage-derived particles for in situ delivery of dna payload into c. acnes population23 Apr 2026US 2026/0109991 A1Eligo Bioscience
Most cited
By later US patents
- Quantitative detection of specific nucleic acid sequences using lambdoid bacteriophages linked by oligonucleotides to solid support39US 5,679,510 AHybridon, Inc. · 1997
- Plasmids and phages for homologous recombination and methods of use5US 7,674,621 B2The United States of America as represented by the Department of Health and Human Services · 2010
- Plasmids and phages for homologous recombination and methods of use5US 8,859,277 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2014
- Method for treatment and control of plant disease5US 9,357,785 B2The Texas A&M University System · 2016
- Method for treatment and control of plant disease4US 10,499,651 B2The Texas A&M University System · 2019